Pages that link to "Q73291422"
Jump to navigation
Jump to search
The following pages link to Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy (Q73291422):
Displaying 50 items.
- Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy (Q21563404) (← links)
- Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials (Q28248717) (← links)
- Progesterone vs placebo therapy for women with epilepsy: A randomized clinical trial. (Q30418813) (← links)
- Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review (Q30703364) (← links)
- Determination of vigabatrin in human plasma by means of CE with LIF detection (Q33298100) (← links)
- Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial-onset seizures: a randomized controlled trial (Q33661884) (← links)
- Rational Polytherapy with Antiepileptic Drugs (Q33664046) (← links)
- Oxcarbazepine, an antiepileptic agent (Q34275202) (← links)
- Oxcarbazepine: an update of its efficacy in the management of epilepsy (Q34312353) (← links)
- Update on treatment of partial onset epilepsy: role of eslicarbazepine (Q34329823) (← links)
- Treating epilepsy in the elderly: safety considerations (Q34458573) (← links)
- Comparative efficacy and tolerability of anti-epileptic drugs for refractory focal epilepsy: systematic review and network meta-analysis reveals the need for long term comparator trials (Q34563933) (← links)
- The clinical impact of new antiepileptic drugs after a decade of use in epilepsy (Q34768780) (← links)
- Overtreatment in adults with epilepsy (Q35006397) (← links)
- Current limitations of antiepileptic drug therapy: a conference review. (Q35063200) (← links)
- New antiepileptic drug therapies. (Q35077748) (← links)
- Selection criteria for the clinical use of the newer antiepileptic drugs. (Q35107733) (← links)
- Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs (Q35172260) (← links)
- Clinical pharmacokinetics of oxcarbazepine (Q35213465) (← links)
- A comprehensive review of the literature on epilepsy in selected countries in emerging markets (Q35327073) (← links)
- Health-related quality of life in senior adults with epilepsy: what we know from randomized clinical trials and suggestions for future research (Q35617844) (← links)
- Adjunctive oxcarbazepine in comorbid anxiety and affective disorder with hyponatremic seizure: case analysis and literature review (Q35617847) (← links)
- Clinically relevant drug interactions with antiepileptic drugs (Q35827491) (← links)
- What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs? (Q35893387) (← links)
- WITHDRAWN: Oxcarbazepine add-on for drug-resistant partial epilepsy. (Q36192524) (← links)
- Long-term safety and tolerability of oxcarbazepine in children: a review of clinical experience (Q36263839) (← links)
- Combination therapy in epilepsy: when and what to use. (Q36622991) (← links)
- Clinical development of antiepileptic drugs in adults (Q36697468) (← links)
- Antiepileptic drugs for the treatment of post-traumatic stress disorder (Q36946123) (← links)
- Antiepileptic drug development in children: considerations for a revisited strategy (Q37032549) (← links)
- Clinical perspectives on lacosamide (Q37156322) (← links)
- Intractable epilepsy: management and therapeutic alternatives (Q37165869) (← links)
- Long-term efficacy and safety of adjunctive extended-release oxcarbazepine (Oxtellar XR® ) in adults with partial-onset seizures (Q37295962) (← links)
- Lacosamide and sodium channel-blocking antiepileptic drug cross-titration against levetiracetam background therapy (Q37696491) (← links)
- The pharmacological treatment of epilepsy in adults (Q37867780) (← links)
- Antiepileptic drug therapy: does mechanism of action matter? (Q37901704) (← links)
- Adjunctive lacosamide in clinical practice: Sodium blockade with a difference? (Q37926255) (← links)
- When one plus one makes three: the quest for rational antiepileptic polytherapy with supraadditive anticonvulsant efficacy (Q38099503) (← links)
- Drug interactions with the newer antiepileptic drugs (AEDs)--part 1: pharmacokinetic and pharmacodynamic interactions between AEDs (Q38115721) (← links)
- Network meta-analyses of antiepileptic drug efficacy and tolerability in drug-resistant focal epilepsies: a clinical perspective (Q38199973) (← links)
- Drug-induced cerebellar ataxia: a systematic review (Q38267726) (← links)
- Is a separate monotherapy indication warranted for antiepileptic drugs? (Q38637882) (← links)
- Antiepileptic Drug Discovery and Development: What Have We Learned and Where Are We Going? (Q38974450) (← links)
- Trial Design: How Do We Figure Out if an AED Works (Q41159843) (← links)
- Efficacy and Tolerability of Second and Third Generation Anti-epileptic Drugs in Refractory Epilepsy: A Network Meta-Analysis (Q42113049) (← links)
- Risk Factors of Oxcarbazepine-Induced Hyponatremia in Patients With Epilepsy (Q42873345) (← links)
- A patient with incomplete seizure control during initial monotherapy with carbamazepine (Q44403063) (← links)
- Increase in dihydroxycarbamazepine serum levels in patients co-medicated with oxcarbazepine and lamotrigine (Q44630860) (← links)
- How is oxcarbazepine different from carbamazpine? (Q44760714) (← links)
- Tricyclic anticonvulsants: safety and adverse effects (Q44892455) (← links)